Sporadic Parathyroid Adenoma: A Pilot Study of Novel Biomarkers in Females
- PMID: 39064529
- PMCID: PMC11279064
- DOI: 10.3390/medicina60071100
Sporadic Parathyroid Adenoma: A Pilot Study of Novel Biomarkers in Females
Abstract
Background and Objectives: Parathyroid adenoma is a distinct cause of primary hyperparathyroidism, with the vast majority being sporadic ones. Proteomic analysis of parathyroid adenomas has proposed a large number of related proteins. The aim of this study is to evaluate the immunohistochemical staining of ANXA2, MED12, MAPK1 and VDR in parathyroid adenoma tissue. Materials and Methods: Fifty-one parathyroid adenomas were analyzed for ANXA2, MED12, MAPK1 and VDR expressions. Tissue was extracted from formalin-fixed paraffin-embedded parathyroid adenoma specimens; an immunohistochemical study was applied, and the percentage of allocation and intensity were evaluated. Results: ANXA2 stained positively in 60.8% of all cell types, while MED12 had positive staining in 66%. MAPK1 expression was found to be negative in total, although a specific pattern for oxyphil cells was observed, as they stained positive in 17.7%. Finally, VDR staining was positive at 22.8%, based on nuclear staining. Conclusions: These immunohistochemical results could be utilized as biomarkers for the diagnosis of sporadic parathyroid adenoma. It is of great importance that a distinct immunophenotype of nodule-forming cells in a positive adenoma could suggest a specific pattern of adenoma development, as in hereditary patterns.
Keywords: ANXA2; MAPK1; MED12; VDR; immunohistochemistry; parathyroid adenoma.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Bilezikian J.P., Brandi M.L., Eastell R., Silverberg S.J., Udelsman R., Marcocci C., Potts J.T. Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the Fourth International Workshop. J. Clin. Endocrinol. Metab. 2014;99:3561–3569. doi: 10.1210/jc.2014-1413. - DOI - PMC - PubMed
-
- Cetani F., Pardi E., Borsari S., Marcocci C. Molecular pathogenesis of primary hyperparathyroidism. J. Endocrinol. Invest. 2011;34:35–39. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
